McKesson, US58155Q1031

McKesson stock trades near 52-week high after strong quarter

Published on 09/06/2026 at 09:06 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

McKesson stock is trading at USD 907.35 after an August 5, 2026 quarter that brought USD 105.38 billion in revenue and EPS of USD 9.93.

Mitarbeiter sortieren unbeschriftete Pakete in einem großen Pharma-Logistiklager mit Regalen
Fotorealistisches Bild zeigt McKesson Corporation ISIN US58155Q1031 als Pharmagroßhändler in modernem Distributionslager mit vielen Mitarbeitern, Illustration mit AI erstellt.

McKesson (ISIN US58155Q1031) stock traded at USD 907.35 on Friday, with a market capitalization of USD 105.79 billion. The latest reported quarter, ended August 5, 2026, showed revenue of USD 105.38 billion and adjusted the earnings picture with EPS of USD 9.93, above the USD 9.56 consensus estimate.

Quarter beats the estimate

The same quarter a year earlier delivered EPS of USD 8.26, so the year-over-year gain was USD 1.67 per share. Revenue rose 7.7 percent from the prior year quarter, while net margin stood at 1.12 percent, according to the latest market-coverage filing page.

That combination matters because the share price is already close to the top of its range: McKesson had a 52-week low of USD 682.35 and a 52-week high of USD 999.00. The stock also changed hands above both its 50-day moving average of USD 848.13 and its 200-day moving average of USD 843.09.

Guidance stays elevated

For the current fiscal year, analysts on MarketBeat cited expected EPS of USD 44.65, while McKesson set FY 2027 guidance at USD 44.2 to USD 45.0 per share. That gives investors two numbered anchors to compare: the latest quarterly beat and a full-year outlook that sits in the mid-40s.

Trading activity points to a valuation that remains rich rather than stretched by the long-term chart alone. The market-cap figure of USD 105.79 billion and the price of USD 907.35 show that investors are still paying up for the distribution and services model.

Go deeper

McKesson earnings and guidance

The August 5, 2026 quarter combined USD 105.38 billion revenue with EPS of USD 9.93 and FY 2027 guidance of USD 44.2 to USD 45.0.

Distribution is the core

McKesson remains a healthcare distribution and services company, and the quarter reinforced how large the core business is: USD 105.38 billion in revenue in one quarter. That scale helps explain why even a 1.12 percent net margin can still translate into a market value above USD 105 billion.

Price stays elevated

As of Friday, the stock was USD 907.35, after trading between USD 682.35 and USD 999.00 over the last 52 weeks. The chart still leaves room below the high, but the current level sits far above both long moving averages and reflects a premium valuation setup.

McKesson at a glance

  • Company: McKesson Corporation
  • ISIN: US58155Q1031
  • Ticker: MCK
  • Trading venue: NYSE
  • Price (as of September 5, 2026): USD 907.35
  • Market capitalization: USD 105.79 billion (as of September 5, 2026)
  • Sector / Industry: Healthcare / Healthcare Distribution
  • Index membership: S&P 500

More on McKesson

Disclaimer...

en | US58155Q1031 | MCKESSON | boerse | 70058861 | bgmi